GeneDx Holdings Corp. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue102.3M121.0M116.7M102.7M87.1M95.6M76.9M70.5M
Cost of Goods Sold34.0M42.1M32.2M31.8M28.6M29.4M29.0M27.6M
Gross Profit68.2M78.9M84.5M70.9M58.5M66.2M47.8M43.0M
R&D Expenses19.8M24.0M19.8M14.9M12.6M11.6M11.7M10.7M
Operating Expenses94.4M92.6M87.8M61.9M63.0M57.4M55.6M53.5M
Operating Income-26.2M-13.7M-3.3M9.0M-4.6M8.8M-7.8M-10.6M
Other Income / Gains-36.2M-4.5M-4.1M1.6M-1.5M-3.4M-579K-18.8M
Net Income-63.3M-17.7M-7.6M10.8M-6.5M5.4M-8.3M-29.2M
EPS (Diluted)-2.16-0.61-0.270.38-0.230.20-0.31-1.10
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.6670.6520.7240.690.6710.6920.6220.609
General And Administrative Expenses047.3M43.7M26.9M32.1M27.4M26.1M25.6M
Selling And Marketing Expenses027.1M23.5M19.4M18.3M17.7M17.0M16.6M
Selling General And Administrative Expenses74.6M74.4M67.2M46.4M50.5M45.0M43.2M42.1M
Other Expenses0-5.8M754K688K0785K774K693K
Cost And Expenses128.4M134.7M120.0M93.7M91.7M86.8M84.7M81.1M
Interest Income00000000
Interest Expense717K520K562K817K640K698K843K894K
Depreciation And Amortization6.8M6.9M6.5M6.2M5.7M5.6M5.9M5.2M
Ebitda-54.9M-10.8M-352K17.6M236K11.7M-1.6M-23.3M
Ebitdaratio-0.537-0.09-0.0030.1710.0030.122-0.021-0.33
Operating Income Ratio-0.256-0.113-0.0280.087-0.0520.092-0.101-0.15
Income Before Tax-62.4M-18.2M-7.4M10.6M-6.1M5.4M-8.4M-29.4M
Income Before Tax Ratio-0.61-0.151-0.0630.103-0.070.057-0.109-0.416
Income Tax Expense897K-564K247K-246K447K-24K-47K-190K
Net Income Ratio-0.619-0.146-0.0650.105-0.0750.057-0.108-0.414
Epsdiluted-2.16-0.59-0.270.36-0.230.20-0.31-1.10
Weighted Average Shs Out29.3M26.9M28.8M28.6M28.1M27.0M27.1M26.6M
Weighted Average Shs Out Dil29.3M26.9M28.8M29.8M28.1M27.0M27.1M26.6M